Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 3 min ago
Peer-reviewedCC BY 4.0ACS Omega

6-Chloropyridinyl Benzoate Fragments as Selective Anti-Melanoma Scaffolds Triggering ROS-Mediated Mitochondrial Apoptosis

  1. 1University of Palermo , , ,
  2. 2Fondazione Umberto Veronesi (FUV) , via Solferino 19 , ,

Abstract

Fragment-like molecules represent valuable starting points in anticancer drug discovery due to their structural simplicity and favorable physicochemical properties. In this context, the combination of phenotypic drug discovery (PDD) with fragment-based drug discovery (FBDD) offers an effective strategy for the rapid identification of bioactive scaffolds. Herein, a small in-house library of 6-chloropyridinyl benzoate fragments was designed to explore the antiproliferative potential of this underexplored scaffold. The compounds were first evaluated in silico, confirming favorable physicochemical and ADME profiles consistent with fragment-like chemical space, and were subsequently synthesized through simple one-pot procedures. Phenotypic screening against a panel of human cancer cell lines (A-375, HCT-116, and MCF-7) revealed a selective antiproliferative effect toward melanoma cells. Two derivatives, 7d and 7k, emerged as the most active compounds, displaying low micromolar activity against A-375 cells (IC50 = 1.59 ± 0.07 μM and 1.08 ± 0.03 μM, respectively) and high selectivity (SI > 60) compared to noncancerous 16-HBE cells. Mechanistic investigations demonstrated that these fragments induce apoptosis through an ROS-dependent mitochondrial pathway, associated with mitochondrial dysfunction and cell cycle arrest at the G1–S transition. Density functional theory (DFT) analysis further suggested that the enhanced electrophilic character and electron-accepting ability of the most active derivatives may contribute to their biological activity. Overall, this study identifies chloropyridinyl benzoate fragments as a previously unexplored scaffold with selective antimelanoma activity and highlights their potential as promising starting points for fragment-to-lead optimization.

Related

  1. Natural product-derived azaphilones are selective scaffolds for covalent lysine liganding in live cells
    W. Ding, S. Brameyer, S. H. Kirsch +5
    bioRxivPreprintCC BYFull textOrganic chemistrybioRxiv
  2. Alteromonas macleodii breaches the diatom frustule triggering protoplast emergence and programmed necrosis-like death in Thalassiosira rotula
    Isobel Short, Clara Martínez-Pérez, Samuel Miravet-Verde +3
    Nature CommunicationsPeer-reviewedCC BY 4.0Full textMaterials & polymersPMC
  3. Self-Assembling Peptide Hydrogels for Mucosal Drug Delivery: Synthesis, Triggering Strategies, and Therapeutic Applications
    Xin Zheng, Susu Jin, Shuyao Zhu +2
    PolymersPeer-reviewedCC BY 4.0Materials & polymersCrossref
  4. Supracolloidal Chains of Patchy Micelles Triggering Förster Resonance Energy Transfer upon Their Growth for Macroscopic Monitoring of Colloidal Assembly.
    Sangyoon Kim, Kyungtae Kim, Jaemin Kim +2
    ACS nanoPeer-reviewedCC BY-NC-NDFull textOrganic chemistryEurope PMC
  5. Enzyme Catalysis: The Effective Molarity for Fragments of Enzyme-Bound Whole Substrates or Active-Site Amino Acid Side Chains.
    John P Richard
    BiochemistryPeer-reviewedCC BY-NC-NDFull textOrganic chemistryEurope PMC
BibTeX
@article{monica20266chloropyridinyl,
  title = {{6-Chloropyridinyl Benzoate Fragments as Selective Anti-Melanoma Scaffolds Triggering ROS-Mediated Mitochondrial Apoptosis}},
  author = {Gabriele La Monica and Ignazio Restivo and Alessia Bono and Federica Alamia and Dennis Tocco and Alessandro Attanzio and Antonino Lauria and Annamaria Martorana},
  journal = {ACS Omega},
  year = {2026},
  month = oct,
  doi = {10.1021/acsomega.6c06714},
  url = {https://pubs.acs.org/acsodf/article/11/42/65020/5449255/6-Chloropyridinyl-Benzoate-Fragments-as-Selective},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - 6-Chloropyridinyl Benzoate Fragments as Selective Anti-Melanoma Scaffolds Triggering ROS-Mediated Mitochondrial Apoptosis
AU  - Gabriele La Monica
AU  - Ignazio Restivo
AU  - Alessia Bono
AU  - Federica Alamia
AU  - Dennis Tocco
AU  - Alessandro Attanzio
AU  - Antonino Lauria
AU  - Annamaria Martorana
PY  - 2026
DA  - 2026/10/12
JO  - ACS Omega
DO  - 10.1021/acsomega.6c06714
UR  - https://pubs.acs.org/acsodf/article/11/42/65020/5449255/6-Chloropyridinyl-Benzoate-Fragments-as-Selective
AB  - Fragment-like molecules represent valuable starting points in anticancer drug discovery due to their structural simplicity and favorable physicochemical properties. In this context, the combination of phenotypic drug discovery (PDD) with fragment-based drug discovery (FBDD) offers an effective strategy for the rapid identification of bioactive scaffolds. Herein, a small in-house library of 6-chloropyridinyl benzoate fragments was designed to explore the antiproliferative potential of this underexplored scaffold. The compounds were first evaluated in silico, confirming favorable physicochemical and ADME profiles consistent with fragment-like chemical space, and were subsequently synthesized through simple one-pot procedures. Phenotypic screening against a panel of human cancer cell lines (A-375, HCT-116, and MCF-7) revealed a selective antiproliferative effect toward melanoma cells. Two derivatives, 7d and 7k, emerged as the most active compounds, displaying low micromolar activity against A-375 cells (IC50 = 1.59 ± 0.07 μM and 1.08 ± 0.03 μM, respectively) and high selectivity (SI > 60) compared to noncancerous 16-HBE cells. Mechanistic investigations demonstrated that these fragments induce apoptosis through an ROS-dependent mitochondrial pathway, associated with mitochondrial dysfunction and cell cycle arrest at the G1–S transition. Density functional theory (DFT) analysis further suggested that the enhanced electrophilic character and electron-accepting ability of the most active derivatives may contribute to their biological activity. Overall, this study identifies chloropyridinyl benzoate fragments as a previously unexplored scaffold with selective antimelanoma activity and highlights their potential as promising starting points for fragment-to-lead optimization.
SN  - 2470-1343
ER  -